Tagged: patent settlement

Brand/generic patent-deal ban nixed

A proposal, backed by the Federal Trade Commission because it would save consumers money, would have banned patent settlements between brand-name and generic drug makers.  But it was dropped from the health-care reform bill because it couldn’t pass muster with Congressional rules.  School of Management Professor Michael Salinger, a former FTC director, the ban still […]